Context: Omentin-1, an adipokine secreted from visceral adipose tissue, has been reported to be associated with coronary artery disease (CAD) and metabolic disorders.
Objective: To clarify the relationship between serum omentin-1 levels and the presence and severity of CAD in patients with metabolic syndrome (MetS).
Methods: We measured serum omentin-1 levels in 175 consecutive patients with MetS and in 46 controls.
Results: Serum omentin-1 levels are inversely associated with the presence and angiographic severity of CAD in MetS patients.
Conclusions: Serum omentin-1 might be a potential biomarker to predict the development and progression of CAD in MetS patients.